CMP-002

N/A

Report date: 2025/12/17 11:13:13
NME

Base Information

Drug NameCMP-002
Drug Alias NameCMP-SYNGAP-01CMP-002
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionRas/Rap GTPase-activating protein SynGAP modulators
TargetsRas/Rap GTPase-activating protein SynGAP
Therapy Area/IndicationsNeurodevelopmental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCamp4 Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesCamp4 Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsNeurodevelopmental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A